Polyethylene Wear Particle Analysis of THA

January 16, 2025 updated by: Yukihide Minoda, Osaka Metropolitan University

Polyethylene Wear Particle Analysis of Total Hip Arthroplasty -International Multicenter Study-

Purpose of research The purpose of this study was to demonstrate that polyethylene (Vitamin E-containing polyethylene), a newly introduced biomaterial for tibial inserts in hip replacement surgery and widely used clinically, but whose mid- to long-term clinical results are still unknown, is superior to conventional polyethylene in vivo. The aim of this project is to conduct an international multi-center joint research study to determine whether polyethylene wear debris production can be reduced in the future, using an in vivo polyethylene wear debris analysis method that the investigators developed as a method that can provide early feedback.

Study Overview

Detailed Description

Research method In this study, the investigators conducted the following steps to determine the in vivo wear particles (number, size, and morphology) of conventional polyethylene, whose long-term results have already been clarified, and vitamin E-containing polyethylene, whose mid- to long-term results have not yet been clarified. Clarifying the difference.

Target of this research In this study, the investigators will focus on patients undergoing revision hip arthroplasty as a routine medical treatment.

First total joint replacement

  • 30 patients using polyethylene containing Vitamin E
  • 30 patients using conventional polyethylene (no high cross-linking)
  • 30 patients using conventional polyethylene (with high cross-linking)

Accumulation of periarticular tissue In this study, the investigators will focus on patients undergoing revision hip arthroplasty as a routine medical treatment.

The test will be conducted after obtaining approval from the ethics committee at each facility and obtaining informed consent. The pericapsular tissue, which is removed during surgery and usually discarded, is obtained and fixed in formalin fixative. The tissue will be transported to the Department of Orthopedic Surgery, Osaka Public University Graduate School of Medicine for analysis. International transportation of tissues requires outsourcing to specialized companies with experience in transporting tissues from overseas.

Isolation of polyethylene wear debris The collected tissue around the joint capsule is immersed in 5Mol sodium hydroxide at 65°C for 1 hour to decompose the protein. Make a sucrose layer (5, 10, 20%) in a 14ml tube (14PA tube, Hitachi Koki Co, Ltd, Tokyo, Japan), add the dissolved solution, and place in an ultracentrifuge (CP100a, P28S1014 rotor, Hitachi Koki). Ultracentrifuge at 28,000 rpm [103,7009g] for 3 hours at 4°C. Prepare an isopropanol layer (0.90 and 0.96 g/mL) in a 40 ml tube (40PA tube, Hitachi Koki Co, Ltd, Tokyo, Japan), add the upper layer of sucrose layer, and centrifuge at 28,000 rpm (103,7009 g) and perform ultracentrifugation at 4°C for 1 hour. The isopropanol interlayer is collected to isolate polyethylene wear debris.

Analysis of polyethylene wear debris The isopropanol interlayer is filtered through a 0.1 μm polycarbonate filter (VCTP 013-00, Millipore Corporation, Bedford, MA). Dry the polycarbonate filter, fix it on an aluminum pedestal (M4, Nisshin EM Co, Ltd, Tokyo, Japan), and apply platinum coating (E-1030 ion sputter, Hitachi Science Systems Ltd, Tokyo, Japan). Observe the polyethylene wear particles on the polycarbonate filter using a scanning electron microscope (S4700SI, Hitachi Ltd, Tokyo, Japan), and analyze the following items using an image analyzer (Mac Scope, Mitani Co, Tokyo, Japan).

  • Number of polyethylene wear particles (number per 1g of tissue)
  • Size (Equivalent circle diameter [μm])
  • Shape (aspect ratio, roundness)

Comparison of iv vivo polyethylene wear powder morphology depending on polyethylene material The number, size, and form of polyethylene wear debris will be compared between conventional polyethylene, whose long-term results have already been clarified, and vitamin E-containing polyethylene, whose medium- to long-term results have not yet been clarified. The investigators also investigated factors that affect polyethylene wear in vivo (age, height, weight, period from initial surgery to revision surgery, hip joint range of motion, hip prosthesis clinical score [Hip dysfunction and Osteoarthritis Outcome Score for Joint Replacement [HOOS Jr], Harris Hip Score, University of California Los Angeles [UCLA] activity score]).

Study Type

Observational

Enrollment (Estimated)

90

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Osaka, Japan, 5458585
        • Recruiting
        • Osaka Metropolitan University
        • Contact:
          • Kiyoko Kato, MD
        • Principal Investigator:
          • Yukihide Minoda
    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Not yet recruiting
        • Mayo Clinic
        • Contact:
        • Principal Investigator:
          • Nicholas A Bedard, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients undergoing revision hip arthroplasty within the study period

Description

Inclusion Criteria:

  1. Patients undergoing revision hip arthroplasty within the study period
  2. Patients over 20 years old
  3. Patients who have received a sufficient explanation, have sufficient understanding, and have given their free written consent.
  4. Patients who have passed 2 years or more since their first total hip arthroplasty

Exclusion Criteria:

1. Patients who are judged to be unsuitable as research subjects by the research physician

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
polyethylene containing Vitamin E
No intervention as this is an observational study
conventional polyethylene (no highly cross-linking)
No intervention as this is an observational study
conventional polyethylene (with highly cross-linking)
No intervention as this is an observational study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of polyethylene wear particles
Time Frame: When tissue sample was collected during THA revision surgery
counts / g (tissue sample)
When tissue sample was collected during THA revision surgery
Equivalent circle diameter of polyethylene wear particles
Time Frame: When tissue sample was collected during THA revision surgery
equivalent circle diameter [㎛]
When tissue sample was collected during THA revision surgery
Aspect ratio of polyethylene wear particles
Time Frame: When tissue sample was collected during THA revision surgery
aspect ratio
When tissue sample was collected during THA revision surgery
Roundness of polyethylene wear particles
Time Frame: When tissue sample was collected during THA revision surgery
roundness
When tissue sample was collected during THA revision surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body mass index
Time Frame: When tissue sample was collected during THA revision surgery
kg/m2
When tissue sample was collected during THA revision surgery
Hip joint flexion angle
Time Frame: When tissue sample was collected during THA revision surgery
Degrees
When tissue sample was collected during THA revision surgery
Hip joint exertion angle
Time Frame: When tissue sample was collected during THA revision surgery
Degrees
When tissue sample was collected during THA revision surgery
Hip joint adduction angle
Time Frame: When tissue sample was collected during THA revision surgery
Degrees
When tissue sample was collected during THA revision surgery
Hip joint abduction angle
Time Frame: When tissue sample was collected during THA revision surgery
Degrees
When tissue sample was collected during THA revision surgery
Hip dysfunction and Osteoarthritis Outcome. Score for Joint Replacement
Time Frame: When tissue sample was collected during THA revision surgery
0(worse)-100(best)
When tissue sample was collected during THA revision surgery
Harris Hip Score
Time Frame: When tissue sample was collected during THA revision surgery
0(worse)-100(best)
When tissue sample was collected during THA revision surgery
University of California at Los Angeles activity score
Time Frame: When tissue sample was collected during THA revision surgery
1(worse)-10(best)
When tissue sample was collected during THA revision surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yukihide Minoda, MD, PhD, Osaka Metropolitan University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2024

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2028

Study Registration Dates

First Submitted

May 16, 2024

First Submitted That Met QC Criteria

May 22, 2024

First Posted (Actual)

May 29, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 16, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • OMU 2023-132

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Arthropathy

Clinical Trials on polyethylene

Subscribe